Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits (ASAM)

November 3, 2026

This guideline provides information on evidence-informed and consensus-based strategies to help clinicians determine whether tapering benzodiazepine (BZD) medications may be appropriate and how to taper them.